FDA Inspection 1242919 — Hunan Dongting Pharmaceutical Co., Ltd.
The FDA completed an inspection of Hunan Dongting Pharmaceutical Co., Ltd. on May 24, 2024 in Changde. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 24, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Changde (China)